These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 31503380)
1. Cyclin D1 immunohistochemical expression and somatic mutations in canine oral melanoma. Zamboni C; Brocca G; Ferraresso S; Ferro S; Sammarco A; Dal Corso C; Iussich S; de Andres PJ; Martìnez de Merlo EM; Cavicchioli L; Zappulli V; Castagnaro M Vet Comp Oncol; 2020 Jun; 18(2):231-238. PubMed ID: 31503380 [TBL] [Abstract][Full Text] [Related]
2. Analysis of KIT expression and KIT exon 11 mutations in canine oral malignant melanomas. Murakami A; Mori T; Sakai H; Murakami M; Yanai T; Hoshino Y; Maruo K Vet Comp Oncol; 2011 Sep; 9(3):219-24. PubMed ID: 21848624 [TBL] [Abstract][Full Text] [Related]
3. The significance of Ki-67 proliferative index and cyclin D1 expression of dysplastic nevi in the biologic spectrum of melanocytic lesions. Lebe B; Pabuççuoğlu U; Ozer E Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):160-4. PubMed ID: 17525627 [TBL] [Abstract][Full Text] [Related]
4. Prognostic value of somatic focal amplifications on chromosome 30 in canine oral melanoma. Prouteau A; Chocteau F; de Brito C; Cadieu E; Primot A; Botherel N; Degorce F; Cornevin L; Lagadic MA; Cabillic F; de Fornel-Thibaud P; Devauchelle P; Derrien T; Abadie J; André C; Hédan B Vet Comp Oncol; 2020 Jun; 18(2):214-223. PubMed ID: 31461207 [TBL] [Abstract][Full Text] [Related]
5. Prognostic evaluation of Ki67 threshold value in canine oral melanoma. Bergin IL; Smedley RC; Esplin DG; Spangler WL; Kiupel M Vet Pathol; 2011 Jan; 48(1):41-53. PubMed ID: 21123859 [TBL] [Abstract][Full Text] [Related]
6. CCND1 amplification and cyclin D1 immunohistochemical expression in head and neck squamous cell carcinomas. Hanken H; Gröbe A; Cachovan G; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M Clin Oral Investig; 2014 Jan; 18(1):269-76. PubMed ID: 23494454 [TBL] [Abstract][Full Text] [Related]
7. CCND1 copy number increase and cyclin D1 expression in acral melanoma: a comparative study of fluorescence in situ hybridization and immunohistochemistry in a Chinese cohort. Liu J; Yu W; Gao F; Qi S; Du J; Ma X; Zhang Y; Zheng J; Su J Diagn Pathol; 2021 Jul; 16(1):60. PubMed ID: 34225728 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of surgical margin, Ki-67 and cyclin D1 protein expression in grade II canine cutaneous mast cell tumor. Ozaki K; Yamagami T; Nomura K; Narama I J Vet Med Sci; 2007 Nov; 69(11):1117-21. PubMed ID: 18057825 [TBL] [Abstract][Full Text] [Related]
9. The role of cyclin D1 and Ki-67 in the development and prognostication of thin melanoma. Kaufmann C; Kempf W; Mangana J; Cheng P; Emberger M; Lang R; Kaiser AK; Lattmann E; Levesque M; Dummer R; Koelblinger P Histopathology; 2020 Sep; 77(3):460-470. PubMed ID: 32374893 [TBL] [Abstract][Full Text] [Related]
10. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Sathyan KM; Nalinakumari KR; Abraham T; Kannan S Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526 [TBL] [Abstract][Full Text] [Related]
11. Alteration in E-cadherin/β-catenin expression in canine melanotic tumors. Han JI; Kim Y; Kim DY; Na KJ Vet Pathol; 2013 Mar; 50(2):274-80. PubMed ID: 22895538 [TBL] [Abstract][Full Text] [Related]
12. Fascin-1 expression in canine cutaneous and oral melanocytic tumours. Yamada N; Mori T; Murakami M; Noguchi S; Sakai H; Akao Y; Maruo K Vet Comp Oncol; 2012 Dec; 10(4):303-11. PubMed ID: 22236355 [TBL] [Abstract][Full Text] [Related]
13. An update on the implications of cyclin D1 in oral carcinogenesis. Ramos-García P; Gil-Montoya JA; Scully C; Ayén A; González-Ruiz L; Navarro-Triviño FJ; González-Moles MA Oral Dis; 2017 Oct; 23(7):897-912. PubMed ID: 27973759 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression and prognostic significance of MAGE-A in canine oral malignant melanoma. Guillén A; Stiborova K; Ressel L; Blackwood L; Finotello R; Amores-Fuster I; Jama N; Killick D Res Vet Sci; 2021 Jul; 137():226-234. PubMed ID: 34023546 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical Expression of Cyclin D1 and Ki-67 in Primary and Metastatic Oral Squamous Cell Carcinoma. Nazar M; Naz I; Mahmood MK; Hashmi SN Asian Pac J Cancer Prev; 2020 Jan; 21(1):37-41. PubMed ID: 31983161 [TBL] [Abstract][Full Text] [Related]
16. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters. Raju B; Mehrotra R; Oijordsbakken G; Al-Sharabi AK; Vasstrand EN; Ibrahim SO Anticancer Res; 2005; 25(6C):4699-706. PubMed ID: 16334163 [TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas. Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423 [TBL] [Abstract][Full Text] [Related]
18. EGFR, HER-2/neu, cyclin D1, p21 and p53 in correlation to cell proliferation and steroid hormone receptor status in ductal carcinoma in situ of the breast. Lebeau A; Unholzer A; Amann G; Kronawitter M; Bauerfeind I; Sendelhofert A; Iff A; Löhrs U Breast Cancer Res Treat; 2003 May; 79(2):187-98. PubMed ID: 12825853 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA Expression in Formalin-Fixed, Paraffin-Embedded Samples of Canine Cutaneous and Oral Melanoma by RT-qPCR. Zamarian V; Catozzi C; Ressel L; Finotello R; Ceciliani F; Vilafranca M; Altimira J; Lecchi C Vet Pathol; 2019 Nov; 56(6):848-855. PubMed ID: 31526125 [TBL] [Abstract][Full Text] [Related]
20. Significance of cytoplasmic cyclin D1 expression in oral oncogenesis. Ramos-García P; Bravo M; González-Ruiz L; González-Moles MÁ Oral Dis; 2018 Mar; 24(1-2):98-102. PubMed ID: 29480608 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]